Sign in

CIK 0000886163 · Large accelerated filer

LIGAND PHARMACEUTICALS INC

Sign in to watch
Tickers
LGND LGNDZ LGNXZ LGNYZ LGNZZ
Exchange
Nasdaq, OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
770160744
Phone
858-550-7500
Business address
3911 SORRENTO VALLEY BLVD, SUITE 110, SAN DIEGO, CA, 92121
Former names
LIGAND PHARMACEUTICALS

Securities

  • LGND Common Stock Nasdaq
  • LGNDZ Common stock OTC
  • LGNXZ Common stock OTC
  • LGNYZ Common stock OTC
  • LGNZZ Common stock OTC
  1. S-8 Other Securities Offered to Employees in Benefit Plans
  2. 10-Q Report Quarterly Report
  3. 8-K Event Results of operations
  4. 8-K Event Executive or director change
  5. 4 Other acquisition EVP,Finance & Strategy and CFO acquired 164 shares (other)
  6. 4 Other acquisition Chief Executive Officer acquired 164 shares (other)
  7. 4 Grant or award Director acquired 1,750 shares (grant or award)
  8. 3 Insider Initial Statement of Ownership
  9. 8-K Event Executive or director change · Regulation FD disclosure
  10. 425 Deal Prospectus/Communication re Business Combination
  11. 8-K Event Regulation FD disclosure
  12. 4 Grant or award SVP, Gen. Counsel & Secretary acquired 5,375 shares (grant or award)
  13. 4 Grant or award President and COO acquired 9,137 shares (grant or award)
  14. 4 Grant or award Chief Executive Officer acquired 20,423 shares (grant or award)
  15. 4 Grant or award EVP,Finance & Strategy and CFO acquired 8,062 shares (grant or award)
  16. 4 Grant or award Director acquired 1,004 shares (grant or award)
  17. 4 Grant or award Director acquired 1,004 shares (grant or award)
  18. 4 Grant or award Director acquired 1,004 shares (grant or award)
  19. 4 Grant or award Director acquired 1,004 shares (grant or award)
  20. 4 Grant or award Director acquired 1,004 shares (grant or award)

Page 21 of 115 · 2,300 filings